VCG
CMD

Vantage Consulting Group’s Cantel Medical Corporation CMD Stock Holding History

Vantage Consulting Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-59
Closed -$5K – 1831
2020
Q4 		$5K Buy
+59
New +$3.46K ﹤0.01% 1463

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vantage Consulting Group's CMD Position: Q1 2021 in Review

Vantage Consulting Group sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 59 shares — an estimated $5K sold.

Vantage Consulting Group first reported a position in CMD in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Vantage Consulting Group reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 59 Cantel Medical Corporation shares in Q1 2021, an estimated $5K.
  • Vantage Consulting Group first reported a position in Cantel Medical Corporation in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Cantel Medical Corporation position peaked at $5K in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.